Published in Diagn Microbiol Infect Dis on May 02, 2008
False positive circumsporozoite protein ELISA: a challenge for the estimation of the entomological inoculation rate of malaria and for vector incrimination. Malar J (2011) 1.55
Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections. Parasite Immunol (2011) 1.40
The natural progression of Gambiense sleeping sickness: what is the evidence? PLoS Negl Trop Dis (2008) 1.31
Atypical human infections by animal trypanosomes. PLoS Negl Trop Dis (2013) 1.01
Diagnostic accuracy of loopamp Trypanosoma brucei detection kit for diagnosis of human African trypanosomiasis in clinical samples. PLoS Negl Trop Dis (2013) 0.98
Importance of nonenteric protozoan infections in immunocompromised people. Clin Microbiol Rev (2010) 0.92
Diagnostic accuracy of molecular amplification tests for human African trypanosomiasis--systematic review. PLoS Negl Trop Dis (2012) 0.90
Trypanosoma lewisi or T. lewisi-like infection in a 37-day-old Indian infant. Am J Trop Med Hyg (2011) 0.86
Phase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda. PLoS Negl Trop Dis (2010) 0.84
Molecular epidemiological studies on animal trypanosomiases in Ghana. Parasit Vectors (2012) 0.82
Treatment of human African trypanosomiasis--present situation and needs for research and development. Lancet Infect Dis (2002) 3.73
Synthetic genetic polymers capable of heredity and evolution. Science (2012) 3.59
Options for field diagnosis of human african trypanosomiasis. Clin Microbiol Rev (2005) 3.12
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci U S A (2005) 2.71
Trypanosoma equiperdum: master of disguise or historical mistake? Trends Parasitol (2005) 2.46
Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II). J Infect Dis (2005) 2.13
International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis (2011) 2.13
Chemical evolution of a bacterium's genome. Angew Chem Int Ed Engl (2011) 2.09
Novel primer sequences for polymerase chain reaction-based detection of Trypanosoma brucei gambiense. Am J Trop Med Hyg (2002) 1.96
A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity. Nucleic Acids Res (2009) 1.84
Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis (2013) 1.82
The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense. Am J Trop Med Hyg (2002) 1.76
Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness. PLoS One (2012) 1.55
How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness. J Infect Dis (2010) 1.53
Towards the Atlas of human African trypanosomiasis. Int J Health Geogr (2009) 1.48
Improved Models of Mini Anion Exchange Centrifugation Technique (mAECT) and Modified Single Centrifugation (MSC) for sleeping sickness diagnosis and staging. PLoS Negl Trop Dis (2009) 1.43
Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. J Clin Invest (2017) 1.39
Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal. PLoS Negl Trop Dis (2012) 1.38
Population genetics of Trypanosoma brucei gambiense, the agent of sleeping sickness in Western Africa. Proc Natl Acad Sci U S A (2008) 1.36
Real-time PCR for detection of Trypanosoma brucei in human blood samples. Diagn Microbiol Infect Dis (2004) 1.34
Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa. PLoS Negl Trop Dis (2010) 1.32
Bioluminescent imaging of Trypanosoma brucei shows preferential testis dissemination which may hamper drug efficacy in sleeping sickness. PLoS Negl Trop Dis (2009) 1.32
Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. J Infect Dis (2003) 1.29
Tripartite interactions between tsetse flies, Sodalis glossinidius and trypanosomes--an epidemiological approach in two historical human African trypanosomiasis foci in Cameroon. Infect Genet Evol (2009) 1.27
Rapid diagnostic test for sleeping sickness. N Engl J Med (2013) 1.26
A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects. Nucleic Acids Res (2010) 1.26
Analysis of the gamma-secretase interactome and validation of its association with tetraspanin-enriched microdomains. Nat Cell Biol (2009) 1.25
Deoxythreosyl phosphonate nucleosides as selective anti-HIV agents. J Am Chem Soc (2005) 1.24
Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study. PLoS Negl Trop Dis (2011) 1.24
Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease. Trop Med Int Health (2008) 1.21
Phenolic profiling of caffeic acid O-methyltransferase-deficient poplar reveals novel benzodioxane oligolignols. Plant Physiol (2004) 1.19
Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa. Bull World Health Organ (2002) 1.17
A simplified and standardized polymerase chain reaction format for the diagnosis of leishmaniasis. J Infect Dis (2008) 1.14
Substituted 5-benzyl-2-phenyl-5H-imidazo[4,5-c]pyridines: a new class of pestivirus inhibitors. Bioorg Med Chem Lett (2006) 1.13
Human African trypanosomiasis: a review of non-endemic cases in the past 20 years. Int J Infect Dis (2011) 1.12
Sleeping sickness diagnosis: use of buffy coats improves the sensitivity of the mini anion exchange centrifugation test. Trop Med Int Health (2010) 1.12
True versus apparent malaria infection prevalence: the contribution of a Bayesian approach. PLoS One (2011) 1.12
alpha-L-ribo-configured locked nucleic acid (alpha-L-LNA): synthesis and properties. J Am Chem Soc (2002) 1.09
Human African trypanosomiasis in South Sudan: how can we prevent a new epidemic? PLoS Negl Trop Dis (2012) 1.09
Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis. J Infect Dis (2009) 1.09
Epidemiology of sleeping sickness in Boffa (Guinea): where are the trypanosomes? PLoS Negl Trop Dis (2012) 1.07
Isolation and purification of a new kalimantacin/batumin-related polyketide antibiotic and elucidation of its biosynthesis gene cluster. Chem Biol (2010) 1.07
Inhibition of MDR1 expression with altritol-modified siRNAs. Nucleic Acids Res (2007) 1.06
Molecular diagnostics for sleeping sickness: what is the benefit for the patient? Lancet Infect Dis (2010) 1.05
Towards understanding the presence/absence of Human African Trypanosomosis in a focus of Côte d'Ivoire: a spatial analysis of the pathogenic system. Int J Health Geogr (2005) 1.04
Nucleotide analogues containing 2-oxa-bicyclo[2.2.1]heptane and l-alpha-threofuranosyl ring systems: interactions with P2Y receptors. Bioorg Med Chem (2004) 1.04
Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol. PLoS Negl Trop Dis (2013) 1.04
Prevalence of human African trypanosomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis (2011) 1.04
[The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense]. Trop Med Int Health (2005) 1.03
Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice. PLoS Negl Trop Dis (2011) 1.03
A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro. Antimicrob Agents Chemother (2010) 1.02
Recognition of threosyl nucleotides by DNA and RNA polymerases. Nucleic Acids Res (2003) 1.02
Discovery of 7-N-piperazinylthiazolo[5,4-d]pyrimidine analogues as a novel class of immunosuppressive agents with in vivo biological activity. J Med Chem (2010) 1.02
Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics. Microbes Infect (2007) 1.02
Atypical human infections by animal trypanosomes. PLoS Negl Trop Dis (2013) 1.01
Correct bond order assignment in a molecular framework using integer linear programming with application to molecules where only non-hydrogen atom coordinates are available. J Chem Inf Model (2005) 1.01
Human African trypanosomiasis: connecting parasite and host genetics. Trends Parasitol (2006) 0.99
Diversity of response to Trypanosoma brucei gambiense infections in the Forecariah mangrove focus (Guinea): perspectives for a better control of sleeping sickness. Microbes Infect (2011) 0.99
Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis. Clin Infect Dis (2008) 0.98
A PKS/NRPS/FAS hybrid gene cluster from Serratia plymuthica RVH1 encoding the biosynthesis of three broad spectrum, zeamine-related antibiotics. PLoS One (2013) 0.98
Diagnostic accuracy of loopamp Trypanosoma brucei detection kit for diagnosis of human African trypanosomiasis in clinical samples. PLoS Negl Trop Dis (2013) 0.98
Identification of stage biomarkers for human African trypanosomiasis. Am J Trop Med Hyg (2010) 0.98
Genetic characterisation of Trypanosoma brucei s.l. using microsatellite typing: new perspectives for the molecular epidemiology of human African trypanosomiasis. Infect Genet Evol (2007) 0.98
Post-transcriptional modification mapping in the Clostridium acetobutylicum 16S rRNA by mass spectrometry and reverse transcriptase assays. Nucleic Acids Res (2007) 0.98
Base pairing properties of D- and L-cyclohexene nucleic acids (CeNA). Oligonucleotides (2003) 0.97
Genetic variability within Trypanosoma brucei gambiense: evidence for the circulation of different genotypes in human African trypanosomiasis patients in Côte d'Ivoire. Trans R Soc Trop Med Hyg (2002) 0.97
Use of the miniature anion exchange centrifugation technique to isolate Trypanosoma evansi from goats. Ann N Y Acad Sci (2004) 0.95
First evidence that parasite infecting apparent aparasitemic serological suspects in human African trypanosomiasis are Trypanosoma brucei gambiense and are similar to those found in patients. Infect Genet Evol (2011) 0.95
Crystal structure of double helical hexitol nucleic acids. J Am Chem Soc (2002) 0.95
Investigation of the DNA-dependent cyclohexenyl nucleic acid polymerization and the cyclohexenyl nucleic acid-dependent DNA polymerization. Nucleic Acids Res (2005) 0.95
The kalimantacin/batumin biosynthesis operon encodes a self-resistance isoform of the FabI bacterial target. Chem Biol (2010) 0.94
Leishmania OligoC-TesT as a simple, rapid, and standardized tool for molecular diagnosis of cutaneous leishmaniasis in Peru. J Clin Microbiol (2009) 0.94
T. cruzi OligoC-TesT: a simplified and standardized polymerase chain reaction format for diagnosis of Chagas disease. PLoS Negl Trop Dis (2009) 0.94
The naturally occurring N6-threonyl adenine in anticodon loop of Schizosaccharomyces pombe tRNAi causes formation of a unique U-turn motif. Nucleic Acids Res (2006) 0.94
Elimination of sleeping sickness hindered by difficult diagnosis. Bull World Health Organ (2013) 0.94
Identification of Trypanosoma brucei circulating in a sleeping sickness focus in Côte d'Ivoire: assessment of genotype selection by the isolation method. Infect Genet Evol (2003) 0.93
Cost-effectiveness of algorithms for confirmation test of human African trypanosomiasis. Emerg Infect Dis (2007) 0.93
A methyl group controls conformational equilibrium in human mitochondrial tRNA(Lys). J Am Chem Soc (2007) 0.92
Identification of Glossina palpalis gambiensis specific salivary antigens: towards the development of a serologic biomarker of human exposure to tsetse flies in West Africa. Microbes Infect (2013) 0.92
Towards a new reference test for surra in camels. Clin Vaccine Immunol (2009) 0.92
Structural characterization and biological evaluation of small interfering RNAs containing cyclohexenyl nucleosides. J Am Chem Soc (2007) 0.92
New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients. Clin Transl Med (2013) 0.92
Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitors. Antimicrob Agents Chemother (2008) 0.92
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing. Bioorg Med Chem Lett (2011) 0.91
Synthesis and evaluation of 5-substituted 2'-deoxyuridine monophosphate analogues as inhibitors of flavin-dependent thymidylate synthase in Mycobacterium tuberculosis. J Med Chem (2011) 0.91
Association between human African trypanosomiasis and the IL6 gene in a Congolese population. Infect Genet Evol (2006) 0.90
Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine. J Neuroimmunol (2003) 0.90
Widespread occurrence of Trypanosoma vivax in bovines of tsetse- as well as non-tsetse-infested regions of Ethiopia: a reason for concern? Vet Parasitol (2012) 0.90
Diagnostic accuracy of molecular amplification tests for human African trypanosomiasis--systematic review. PLoS Negl Trop Dis (2012) 0.90
Synthesis and Antiviral Activity of the alpha-Analogues of 1,5-Anhydrohexitol Nucleosides (1,5-Anhydro-2,3-dideoxy-D-ribohexitol Nucleosides). J Org Chem (1997) 0.90